|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Total revenues | |||||
| Operating costs and expenses: | |||||
| Direct costs | |||||
| Sales and marketing | |||||
| Research, development, and engineering | |||||
| General, administrative, and other related costs | |||||
| Depreciation and amortization | |||||
| Goodwill impairment | |||||
| Total operating costs and expenses | |||||
| Income from operations | |||||
| Interest expense, net | |||||
| Gain on debt extinguishment, net | |||||
| Loss on sale of businesses | |||||
| Unrealized (loss) gain on short-term investments held at the reporting date, net | |||||
| Gain (loss) on investments, net | |||||
| Provision for credit losses on investments | |||||
| Other (loss) income, net | |||||
| Income before income tax expense and (loss) income from equity method investment | |||||
| Income tax expense | |||||
| (Loss) income from equity method investment, net of tax | |||||
| Net income from continuing operations | |||||
| Loss from discontinued operations, net of tax | |||||
| Net income | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Net income per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Share-based compensation expense | |||||
| Cost of revenues | |||||
| Sales and marketing | |||||
| Research, development and engineering | |||||
| General and administrative | |||||
| Total share-based compensation expense | |||||
Loading...